Anorexia and cachexia, asthenia, and lethargy

Hematology/Oncology Clinics of North America

Volumn 10, Issue 1, 1996, Pages 189-206

  Watanabe, S ^a   Bruera, E ^a  

^a GREY NUNS COMMUNITY HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABINOID; CORTICOSTEROID; CYPROHEPTADINE; DEXAMETHASONE; DEXAMPHETAMINE; HYDRAZINE SULFATE; ICOSAPENTAENOIC ACID; MEGESTROL ACETATE; METHYLPHENIDATE; METHYLPREDNISOLONE; MORPHINE; OPIATE AGONIST; PENTOXIFYLLINE; PREDNISOLONE; PSYCHOSTIMULANT AGENT;

ADVANCED CANCER; ANOREXIA; ASTHENIA; CACHEXIA; DIET THERAPY; DOSE RESPONSE; EDEMA; HUMAN; IMPOTENCE; INTRAVENOUS DRUG ADMINISTRATION; LETHARGY; MALNUTRITION; NAUSEA; NEUROTOXICITY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REVIEW; THROMBOEMBOLISM; VAGINA BLEEDING; WEIGHT REDUCTION;

EID: 0030049487     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8588(05)70334-8     Document Type: Article

References (99)

1. R. Adams Anxiety, depression, asthenia and personality disorders R. Petersdorf R. Adams E. Braunwald Harrison's Principles of Internal Medicine 1983 McGraw-Hill New York 68 75
2. H.R. Alexander J.A. Norton Pathophysiology of cancer cachexia D. Doyle G. Hanks N. Macdonald Oxford Textbook of Palliative Medicine 1993 Oxford University Press London 316 329
3. J.E. Beal R. Olson L. Laubenstein J.O. Morales Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS Journal of Pain and Symptom Management 10 1995 89 97
4. S.A. Beck M.J. Tisdale Production of lipolytic and proteolytic factors by a murine tumor producing cachexia in the host Cancer Res 47 1987 5919 5923
5. S.A. Beck K.S. Smith M.J. Tisdale Anticachexic and antitumor effect of eicosapentaenoic acid and its effect on protein turnover Cancer Res 51 1991 6089 6093
6. B. Beutler A. Cerami Cachectin: More than a tumor necrosis factor N Engl J Med 316 1987 379 385
7. E. Bruera Clinical management of cachexia and anorexia in patients with advanced cancer Oncology 49 Suppl 2 1992 35 42
8. E. Bruera R.N. MacDonald Asthenia in patients with advanced cancer Journal of Pain and Symptom Management 3 1988 9 14
9. E. Bruera R.L. Fainsinger Clinical management of cachexia and anorexia D. Doyle G. Hanks N. MacDonald Oxford Textbook of Palliative Medicine 1993 Oxford Medical Publications London 330 337
10. E. Bruera R.N. MacDonald Nutrition in patients with advanced cancer: An update and review of our experience Journal of Pain and Symptom Management 3 1988 133 140
11. E. Bruera Z. Catz R. Hooper Chronic nausea and anorexia in patients with advanced cancer: A possible role for autonomic dysfunction Journal of Pain and Symptom Management 2 1987 19 21
12. E. Bruera S. Chadwick N. MacDonald Study of cardiovascular autonomic insufficiency in advanced cancer patients Cancer Treatment Report 70 1986 1383 1387
13. E. Bruera L. Cowan S. Chadwick Caloric intake assessment in advanced cancer patients: A comparison of three methods Cancer Treatment Report 70 1986 981 983
14. E. Bruera M.A. Legris N. Kuehn M.J. Miller Hypodermoclysis for the administration of fluids and narcotic analgesics in patients with advanced cancer Journal of Pain and Symptom Management 5 1990 218 220
15. E. Bruera E. Roca L. Cedaro Action of oral methylprednisolone in terminal cancer patients: A prospective randomized double-blind study Cancer Treatment Report 69 1985 751 754
16. E. Bruera K. Macmillan J. Hanson A controlled trial of megestrol acetate on appetite, caloric intake, nutritional status, and other symptoms in patients with advanced cancer Cancer 66 1990 1279 1282
17. E. Bruera C. Brenneis M. Michaud Association between involuntary muscle function (IMF) and asthenia (AST), nutritional status (NS), lean body mass (LBM), psychometric assessment and tumor mass (TM) in patients (PTS) with advanced breast cancer Proc Am Soc Clin Oncol 6 1987 261
18. E. Bruera C. Brenneis M. Michaud Association between asthenia and nutritional status, lean body mass, anemia, psychometrical status and tumor mass in patients with advanced breast cancer Journal of Pain and Symptom Management 4 1989 59 63
19. E. Bruera F. Jackson M. Michaud Muscle electrophysiology in patients with advanced breast cancer J Natl Cancer Inst 80 1988 282 286
20. E. Bruera C. Brenneis S. Chadwick Methylphenidate associated with narcotics for the treatment of cancer pain Cancer Treatment Report 71 1987 67 70
21. E. Bruera L. Miller J. McCallion Cognitive failure in patients with terminal cancer: A prospective study Journal of Pain and Symptom Management 7 1992 192 195
22. E. Bruera M.J. Miller K. Macmillan N. Kuehn Neuropsychological effects of methylphenidate in patients receiving a continuous infusion of narcotics for cancer pain Pain 48 1992 163 166
23. E. Bruera R. Fainsinger T. MacEachern J. Hanson The use of methylphenidate in patients with incident cancer pain receiving regular opiates. A preliminary report Pain 50 1992 75 77
24. A. Burfoot The brain connection Runners World 29 1994 70 75
25. F. Cavalli A. Goldhirsch I.F. Young Randomized trial of low vs. high dose medroxyprogesterone acetate in the treatment of postmenopausal patients with advanced breast cancer A. Pellegrini G. Robustelli Role of Medroxyprogesterone in Endocrine-Related Tumors 1983 Raven Press New York 69 76
26. R.T. Chlebowski L. Bulcavate M. Grosvenor Hydrazine sulfate in cancer patients with weight loss: A placebo controlled clinical experience Cancer 59 1987 406 410
27. R.T. Chlebowski L. Bulcavate M. Grosvenor Hydrazine sulfate influence on nutritional status and survival in non small cell lung cancer J Clin Oncol 8 1990 9 15
28. N. Coyle J. Adelhardt K. Foley R. Portenoy Character of terminal illness in the advanced cancer patient: Pain and other symptoms during the last four weeks of life Journal of Pain and Symptom Management 5 1990 83 93
29. W.D. DeWys C. Begg P.T. Lavin Prognostic effect of weight loss prior to chemotherapy in cancer patients Am J Med 69 1980 491 497
30. B.J. Dezube M.L. Sherman J.L. Friadovich-Keil Down-regulation of tumor necrosis factor expression by pentoxifylline in cancer patients: A pilot study Cancer Immunotherapy 36 1993 57 60
31. S. Donnelly D. Walsh The symptoms of advanced cancer: Identification of clinical and research priorities by assessment of prevalence and severity J Palliat Care 11 1995 27 32
32. W. Evans D. Nixon J. Daly A randomized study of standard or augmented oral nutritional support versus ad lib nutrition intake in patients with advanced cancer [abstract] Clin Invest Med 9 1986 A 127
33. R. Fainsinger E. Bruera M.J. Miller Symptom control during the last week of life on a palliative care unit J Palliat Care 7 1991 5 11
34. F. Fernandez F. Adams V. Holmes J. Levy Methylphenidate for depressive disorders in cancer patients Psychosomatics 28 1987 455 461
35. M. Folstein J. Fetting A. Lovo Cognitive assessment of cancer patients Cancer 53 1989 2150 2157
36. R.W. Foltin M.W. Fischman M.F. Byrne Effects of smoked marijuana on food intake and body weight of humans living in a residential laboratory Appetite 11 1988 1 14
37. E.P. Grandjean Fatigue: Yank Memorial Lecture 1970 American Industrial Hygiene Association Journal 31 1970 401 411
38. J.R. Hayes Depression and chronic fatigue in cancer patients Primary Care 18 1991 327 339
39. R. Holroyde R.S. Axelrod C.L. Skutchers Lactate metabolism in patients with metastatic colorectal cancer Cancer Res 39 1979 4900 4904
40. T.K. Hughes P. Cadet C.S. Larnad Modulation of tumor necrosis factor activities by potential anticachexia compound hydrazine sulfate Int J Immunopharmacol 11 1989 501 507
41. D.M. Irvine L. Vincent N. Bubela A critical appraisal of the research literature investigating fatigue in the individual with cancer Cancer Nursing 14 1991 188 199
42. J. Jones G. Ray L. Minnich Evidence for active Epstein-Barr virus infection in patients with persistent, unexplained illnesses. Elevated anti-early antigen antibodies Ann Intern Med 102 1985 1 7
43. Kaasa T, Gillis K, Middleton E, Bruera E: The Edmonton Functional Assessment Tool (EFAT) for terminal cancer patients. Presented at the 9th Lntl Congress on Care of the Terminally Ill, Montreal, Nov 1-2, 1992
44. C. Kardinal C.L. Loprinzi D.J. Schaid A controlled trial of cyproheptadine in cancer patients with anorexia and/or cachexia Cancer 65 1990 2657 2662
45. J.A.M. Kobashi-Schoot F.J.F.P. Hanewald F.S.A.M. van Dam Assessment of malaise in cancer treated with radiotherapy Cancer Nursing 8 1985 306 314
46. R. Koretz Parenteral nutrition: Is it oncologically logical? J Clinical Oncol 2 1984 534 538
47. M.P. Kosty S.B. Fleishman J.E. Herndon Cisplatin, vinblastine, and hydrazine sulfate in advanced non-small-cell lung cancer: A randomized placebo-controlled, double-blind phase III study of the Cancer and Leukemia Group B J Clin Oncol 12 1994 1113 1120
48. J. Lehman J. De Lisa C. Warren Cancer rehabilitation: Assessment of need, development and evaluation of a model care Arch Phys Med Rehabil 59 1978 410 419
49. Z.J. Lipowski Delirium in the elderly patient N Engl J Med 320 1989 578 582
50. C.L. Loprinzi N.M. Ellison D.J. Schaid Controlled trial of megestrol acetate for the treatment of cancer, anorexia and cachexia J Natl Cancer Inst 82 1990 1127 1132
51. C.L. Loprinzi J.C. Michalak D.J. Schaid Phase three evaluation of four doses of megestrol acetate as therapy for patients with cancer anorexia and/or cachexia J Clin Oncol 11 1993 762 767
52. C.L. Loprinzi D.J. Schaid A.N. Dose Body-composition changes in patients who gain weight while receiving megestrol acetate J Clin Oncol 11 1993 152 154
53. C.L. Loprinzi R.M. Goldberg N.L. Burnham Cancer-associated anorexia and cachexia Drugs 43 1992 499 506
54. C.L. Loprinzi S.A. Kuross J.R. O'Fallon Randomized placebo-controlled evaluation of hydrazine sulfate in patients with advanced colorectal cancer J Clin Oncol 12 1994 1121 1125
55. C.L. Loprinzi R.M. Goldberg J.Q. Su Placebo-controlled trial of hydrazine sulfate in patients with newly diagnosed non-small-cell lung cancer J Clin Oncol 12 1994 1126 1129
56. S. Mahony S. Beck M. Tisdale Comparison of a weight loss induced by recombinant tumor necrosis factor with that produced by a chachexia-induced tumor Br J Cancer 57 1988 385 389
57. J. Minna G. Higgins E. Glastein Cancer of the lung V. De Vita S. Hellmann S. Rosenberg Cancer: Principles and Practice of Oncology 1985 JB Lippincott New York
58. C. Moertel A.G. Schutt R.J. Reiteneier R.G. Hahn Corticosteroid therapy of preterminal gastrointestinal cancer Cancer 33 1974 1607 1609
59. K. Nelson D. Walsh P. Deeter A phase II study of delta-nine-tetrahydrocannabinol for appetite stimulation in cancer-associated anorexia J Palliat Care 10 1994 14 18
60. R.E. Noble Effect of Cyproheptadine on appetite and weight gain in adults JAMA 209 1969 2054 2055
61. P. Noel S. Nelson R. Bokulic Pentoxifylline inhibits lipopolysaccharide-induced serum tumor necrosis factor and mortality Life Signs 47 1990 1023 1029
62. A. Oliff D. Defeo-Jones M. Boxer Tumors secreting human TNF/cachectin induced cachexia in mice Cell 50 1987 555 563
63. G. Pawlowski Cyproheptadine: Weight gain and appetite stimulation in essential anorexia adults Curr Ther Res 18 1975 673 678
64. P.G. Pearson G.E. Byars The development and validation of a checklist measuring subjective fatigue. Report no. 556-115 1956 School of Aviation USAF, Randolf AFB, Texas
65. B.F. Piper Fatigue V.K. Carrieri A.M. Lindsey C.M. West Pathophysiology Phenomena in Nursing: Human Response to Illness 1986 WB Saunders Philadelphia 219 234
66. Piper BF: Fatigue. In Trans-cultural implications for nursing interventions. Presented at the Sixth International Conference on Cancer Nursing, Amsterdam, 1990
67. B.F. Piper A.M. Lindsey M.J. Dodd The development of an instrument to measure the subjective dimension of fatigue S.G. Funk E.M. Tornquist M.T. Champagne Key Aspects of Comfort. Management of Pain, Fatigue and Nausea 1989 Springer Publishing New York
68. M. Platt W. Breitbart M. Smith Efficacy of neuroleptics for hypoactive delirium [letter] J Neuropychiatry 6 1994 66
69. F. Plum Asthenia, weakness and fatigue J. Wyngaaarden L. Smith Cecil Textbook of Medicine. 1985 WB Saunders Philadelphia 2044
70. T. Popiela R. Lucchi F. Giongo Methylprednisolone as palliative therapy for female terminal cancer patients Eur J Cancer Clin Oncol 25 1989 1823 1829
71. S.J. Proctor J. Kernahan P. Taylor Depression as a component of post-cranial irradiation somnolence syndrome Lancet 1 1981 1215 1216
72. B.D. Ray R.L. Hanson H.A. Lardy Inhibition by hydrazine of gluconeogenesis in the rat J Biol Chem 5 1970 690 696
73. D. Rhoten Fatigue and postsurgical patient C.M. Norris Concept Clarification in Nursing 1982 Aspen Publishers Rockville, MD 277 300
74. G. Robustelli Della Cuna A. Pellegrini M. Piazzi Effect of methylprednisolone sodium on quality of life in pre-terminal cancer patients: A placebo controlled multicenter study Eur J Cancer Clin Oncol 25 1989 1817 1821
75. P. Rosenberg J. Ahmed S. Hurwitz Methylphenidate in depressed medically ill patients J Clin Psychiatry 52 1991 263 267
76. C.A. Ross CNS arousal systems: Possible role in delirium Int Psychogeriatr 3 1991 353 371
77. U.F. Schade Pentoxifylline increases survival in marine endotoxin shock and decreases formation of tumor necrosis factor Circ Shock 31 1990 171 181
78. N. Shah A double-blind study on appetite stimulation and weight gain with cyproheptadine adjunct to specific therapy in pulmonary tuberculosis Current Medical Practice 12 1968 861 864
79. R. Silverstein P. Bhatia D.S. Svoboda Effect of hydrazine sulfate on glucose-regulating enzymes in the normal and cancerous rat Immunopharmacology 17 1989 37 43
80. M.J. Smith W.S. Breitbart M.M. Platt A critique of instruments and methods to detect, diagnose and rate delirium Journal of Pain and Symptom Management 10 1994 35 77
81. S. Stauss G. Tosato G. Armstrong Persistent illness and fatigue in adults with evidence Epstein-Barr virus infection Ann Intern Med 102 1985 7 16
82. J.A. Tayek D. Herber R.T. Chlebowski Effect of hydrazine sulfate on whole body protein breakdown measured by C-lysine metabolism in lung cancer patients Lancet 2 1984 241 244
83. S. Tchekmedyian N. Tait M. Moody High dose megestrol acetate: A possible treatment for cachexia JAMA 257 1987 1195 1199
84. S. Tchekmedyian N. Tait M. Moody Appetite stimulation with megestrol acetate in cachectic cancer patients Semin Oncol 13 1986 37 43
85. S. Tchekmedyian M. Hakman J. Siau Megestrol acetate in cancer anorexia and weight loss Cancer 69 1992 1268 1274
86. A. Theologides Asthenia in cancer Am J Med 73 1982 1 3
87. A. Theologides Asthenins and cachectins in cancer Am J Med 81 1986 969 968
88. M.J. Tisdale S.A. Beck Inhibition of tumor-induced lipolysis in vitro and cachexia and tumor growth in vivo by eicosapentaenoic acid Biochem Pharmocol 41 1991 103 107
89. M. Torosian J. Daly Nutritional support in the cancer-bearing host Cancer 58 1986 1915 1929
90. R. Wadleigh M. Spaulding B. Lembersky Dronabinol enhancement of appetite and cancer patients Proc Am Soc Clin Oncol 9 1990 331
91. T. Walsh C. Saunders Hospice care: The treatment of pain in advanced cancer Recent Results cancer res 89 1984 201 211
92. H.M. Warenius Paraneoplastic neurological syndromes R. Tallis The Clinical Neurology of Old Age 1989 John Wiley and Sons New York 323 334
93. J.R. Warmolts P.K. Re R.J. Lewis W.K. Engel Type II muscle fiber atrophy (II-atrophy): An early systemic effect of cancer Neurology 2 1975 374
94. S. Warren The immediate cause of death in cancer Am J Med Sci 184 1932 610 613
95. N. Weiner Amphetamine L. Goodman A. Gilman The Pharmacological Basis for Therapeutics 1980 MacMillan New York 159 162
96. C.N. Williams New steroids Can J Gastroenterol 7 1993 588
97. J. Willox J. Corr J. Shaw Prednisolone as an appetite stimulant in patients with cancer Br Med J 200 1984 37
98. M.B. Wilwerding C. Loprinzi J. Milliard A randomized crossover evaluation of methylphenidate in cancer patients receiving strong narcotics Proc Am Soc Clin Oncol 28 1993 455 461
99. P. Zabel M.M. Schonharting D.T. Wolter Oxpentifylline in endotoxaemia Lancet 1989 1474 1477